Publications

  1. Brown LC, Laack TA, Ma DJ, Olivier KR, Laack NN. Multidisciplinary medical simulation: a novel educational approach to preparing radiation oncology residents for oncologic emergent on-call treatments. Int J Radiat Oncol Biol Phys. 2014 Nov 1; 90(3):705-6. Epub 2014 Sep 26.
    View PubMed
  2. Lester RA, Brown LC, Eckel LJ, Foote RT, NageswaraRao AA, Buckner JC, Parney IF, Wetjen NM, Laack NN. Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor. J Neurooncol. 2014 Nov; 120(2):371-9. Epub 2014 Aug 13.
    View PubMed
  3. Kizilbash SH, Giannini C, Voss JS, Decker PA, Jenkins RB, Hardie J, Laack NN, Parney IF, Uhm JH, Buckner JC. The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma. J Neurooncol. 2014 Oct; 120(1):85-93. Epub 2014 Jul 04.
    View PubMed
  4. Ahmed SK, Robinson SI, Okuno SH, Rose PS, Issa Laack NN. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease. Am J Clin Oncol. 2014 Oct; 37(5):423-9.
    View PubMed
  5. Brown L, Harmsen W, Blanchard M, Goetz M, Jakub J, Mutter R, Petersen I, Rooney J, Stauder M, Yan E, Laack N. Once-daily radiation therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2014 Aug 1; 89(5):997-1003. Epub 2014 Apr 07.
    View PubMed
  6. Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):e143-9. Epub 2013 Jun 29.
    View PubMed
  7. Ahmed KA, Laack NN, Eckel LJ, Orme NM, Wetjen NM. Histologically proven, low-grade brainstem gliomas in children: 30-year experience with long-term follow-up at Mayo Clinic. Am J Clin Oncol. 2014 Feb; 37(1):51-6.
    View PubMed
  8. Call JA, Naik M, Rodriguez FJ, Giannini C, Wu W, Buckner JC, Parney IF, Laack NN. Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma. Am J Clin Oncol. 2014 Feb; 37(1):1-7.
    View PubMed
  9. Kazda T, Jancalek R, Pospisil P, Sevela O, Prochazka T, Vrzal M, Burkon P, Slavik M, Hynkova L, Slampa P, Laack NN. Why and how to spare the hippocampus during brain radiotherapy: The developing role of hippocampal avoidance in cranial radiotherapy. Radiat. oncol. 2014; 9(1):139.
  10. Youland RS, Brown PD, Giannini C, Parney IF, Uhm JH, Laack NN. Adult low-grade glioma: 19-year experience at a single institution. Am J Clin Oncol. 2013 Dec; 36(6):612-9.
    View PubMed
  11. Rooney JW, Laack NN. Pharmacological interventions to treat or prevent neurocognitive decline after brain radiation. CNS Oncol. 2013 Nov; 2(6):531-41.
    View PubMed
  12. Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, Choucair A, Fox S, Suh JH, Roberge D, Kavadi V, Bentzen SM, Mehta MP, Watkins-Bruner D, Radiation Therapy Oncology Group (RTOG). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013 Oct; 15(10):1429-37. Epub 2013 Aug 16.
    View PubMed
  13. Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR. Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol. 2013 Oct; 36(5):509-13.
    View PubMed
  14. Barney BM, Markovic SN, Laack NN, Miller RC, Sarkaria JN, Macdonald OK, Bauer HJ, Olivier KR. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys. 2013 Sep 1; 87(1):73-80.
    View PubMed
  15. Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. Neuro Oncol. 2013 Aug; 15(8):1058-67. Epub 2013 Mar 3
    View PubMed
  16. Youland RS, Schomas DA, Brown PD, Nwachukwu C, Buckner JC, Giannini C, Parney IF, Laack NN. Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years. Neuro Oncol. 2013 Aug; 15(8):1102-10. Epub 2013 Jun 27.
    View PubMed
  17. Nagata S, Shen RK, Laack NN, Inwards CY, Wenger DE, Amrami KK. Chondrosarcoma arising within a radiation-induced osteochondroma several years following childhood total body irradiation: case report. Skeletal Radiol. 2013 Aug; 42(8):1173-7. Epub 2013 Apr 11.
    View PubMed
  18. Merchant TE, Hodgson D, Laack NN, Wolden S, Indelicato DJ, Kalapurakal JA, COG Radiation Oncology Discipline Committee. Children's Oncology Group's 2013 blueprint for research: radiation oncology. Pediatr Blood Cancer. 2013 Jun; 60(6):1037-43. Epub 2012 Dec 19
    View PubMed
  19. Youland RS, Khwaja SS, Schomas DA, Keating GF, Wetjen NM, Laack NN. Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades. J Pediatr Hematol Oncol. 2013 Apr; 35(3):197-205.
    View PubMed
  20. Cheville AL, Brinkmann DH, Ward SB, Durski J, Laack NN, Yan E, Schomberg PJ, Garces YI, Suman VJ, Petersen IA. The addition of SPECT/CT lymphoscintigraphy to breast cancer radiation planning spares lymph nodes critical for arm drainage. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):971-7.
    View PubMed
  21. Robinson SI, Ahmed SK, Okuno SH, Arndt CA, Rose PS, Laack NN. Clinical Outcomes of Adult Patients With Relapsed Ewing Sarcoma: A 30-Year Single-Institution Experience. Am J Clin Oncol. 2013 Mar 04. [Epub ahead of print]
    View PubMed
  22. Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, Giannini C, Laack NN, Parney IF, Lowe VJ, Brinkmann DH, Sarkaria JN. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. J Neurooncol. 2013 Jan; 111(1):11-8. Epub 2012 Oct 20.
    View PubMed
  23. Ahmed SK, Robinson SI, Okuno SH, Rose PS, Laack NN. Adult ewing sarcoma: survival and local control outcomes in 102 patients with localized disease. Sarcoma. 2013; 2013:681425. Epub 2013 Jun 11.
    View PubMed
  24. Compton JJ, Laack NN, Eckel LJ, Schomas DA, Giannini C, Meyer FB. Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic. J Neurosurg. 2012 Nov; 117(5):825-30. Epub 2012 Sep 7.
    View PubMed
  25. Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012 May; 87(5):475-87.
    View PubMed
  26. Caine C, Mehta MP, Laack NN, Gondi V. Cognitive function testing in adult brain tumor trials: lessons from a comprehensive review. Expert Rev Anticancer Ther. 2012 May; 12(5):655-67.
    View PubMed
  27. Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82(5):e803-9. Epub 2012 Feb 11.
    View PubMed
  28. Bram RJ, Laack NNI. Protons: Moving therapy for hodgkin lymphoma in a positive direction. ONCOLOGY (United States). 2012; 26(5).
  29. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012; 7:174. Epub 2012 Oct 22.
    View PubMed
  30. Laack NN, O'Neill BP, Ballman KV, O'Fallon JR, Carrero XW, Kurtin PJ, Scheithauer BW, Brown PD, Habermann TM, Colgan JP, Gilbert MR, Hawkins RB, Morton RF, Windschitl HE, Fitch TR, Pajon ER Jr, North Central Cancer Treatment Group and Mayo Clinic. CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys. 2011 Oct 1; 81(2):476-82. Epub 2010 Aug 26.
    View PubMed
  31. Stauder MC, Laack NN, Moir CR, Schomberg PJ. Excellent local control and survival after intraoperative and external beam radiotherapy for pediatric solid tumors: long-term follow-up of the Mayo Clinic experience. J Pediatr Hematol Oncol. 2011 Jul; 33(5):350-5.
    View PubMed
  32. Laack TA, Thompson KM, Kofler JM, Bellolio MF, Sawyer MD, Laack NN. Comparison of trauma mortality and estimated cancer mortality from computed tomography during initial evaluation of intermediate-risk trauma patients. J Trauma. 2011 Jun; 70(6):1362-5.
    View PubMed
  33. Jensen AW, Laack NN, Buckner JC, Schomberg PJ, Wetmore CJ, Brown PD. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. Int J Radiat Oncol Biol Phys. 2010 Aug 1; 77(5):1449-56. Epub 2010 Jan 04.
    View PubMed
  34. Rao AA, Laack NN, Giannini C, Wetmore C. Pleomorphic xanthoastrocytoma in children and adolescents. Pediatr Blood Cancer. 2010 Aug; 55(2):290-4.
    View PubMed
  35. Schomas DA, Laack NN, Brown PD. Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic. Cancer. 2009 Sep 1; 115(17):3969-78.
    View PubMed
  36. Schomas DA, Laack NN, Rao RD, Meyer FB, Shaw EG, O'Neill BP, Giannini C, Brown PD. Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol. 2009 Aug; 11(4):437-45. Epub 2008 Nov 18.
    View PubMed
  37. Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008 Oct; 9(10):993-1001.
    View PubMed
  38. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008 Jan; 83(1):97-112.
    View PubMed
  39. Long HJ 3rd, Laack NN, Gostout BS. Prevention, diagnosis, and treatment of cervical cancer. Mayo Clin Proc. 2007 Dec; 82(12):1566-74.
    View PubMed
  40. Laack NN, Ballman KV, Brown PB, O'Neill BP, North Central Cancer Treatment Group. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51. Int J Radiat Oncol Biol Phys. 2006 Aug 1; 65(5):1429-39.
    View PubMed
  41. Laack NN, Brown PD, Ivnik RJ, Furth AF, Ballman KV, Hammack JE, Arusell RM, Shaw EG, Buckner JC. Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1175-83.
  42. Laack NN, Brown PD. Cognitive sequelae of brain radiation on adults. Semin Oncol. 2004 Oct; 31(5):702-13.
    View PubMed
  43. De Leon DD, Issa N, Nainani S, Asmerom Y. Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II). Horm Metab Res. 1999 Feb-Mar; 31(2-3):142-7.
    View PubMed